PHGE Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
332.0K
0
0
0
0
Cost of Revenue
235.0K
0
0
0
0
Gross Profit
97.0K
0
0
0
0
Operating Expenses
5.5M
+325.2%
1.3M
-92.7%
17.7M
+107.8%
8.5M
+14.8%
7.4M
R&D
128.0K
+140.6%
-315000
-106.4%
4.9M
-19.9%
6.1M
+22.1%
5.0M
SG&A
5.4M
+234.1%
1.6M
-29.6%
2.3M
-5.2%
2.4M
-0.2%
2.4M
Operating Income
-5414000
-317.7%
-1296000
+92.7%
-17741000
-107.8%
-8536000
-14.8%
-7433000
EBITDA
-5409000
-317.4%
-1296000
+58.1%
-3093000
+57.6%
-7295000
-2.2%
-7141000
Net Income
-3846000
+79.9%
-19140000
-43.5%
-13337000
-45.5%
-9166000
-51.8%
-6037000
EPS (Basic)
$-0.37
+95.0%
$-7.38
$-5.51
-50.5%
$-3.66
EPS (Diluted)
$-0.37
+95.0%
$-7.38
$-5.51
-50.5%
$-3.66
Shares (Diluted)
10.3M
+296.1%
2.6M
1.7M
+0.3%
1.6M
BiomX (PHGE) — Financials